1. AACR Task Force on the Treatment and Prevention of Intraepithelial Neoplasia (IEN) (2001) Treatment and prevention of IEN: an important target for accelerated new agent development. Clin Cancer Res 8:314–346
2. Adam BL, Qu Y, Davis J et al. (2002) Serum protein fingerprinting coupled with a pattern matching algorithm that distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res 62:3609–3614
3. Alpha Tocopherol, Beta Carotene Cancer Prevention Study Group (1994) The effect of vitamin E and beta carotene on the incidence of lung cancers and other cancers in male smokers. N Engl J Med 330:1029–1035
4. Betz J (2001) Trial endpoints for drug approval in oncology: chemoprevention. Urology 57 (Suppl 4A):213–216
5. Bonham M, Arnold H, Montgomery B, Nelson PS (2002) Molecular effects of the herbal compound PCSPES: identification of activity pathways in prostate carcinoma. Cancer Res 62:3920–3924